Cetera Investment Advisers Boosts Holdings in Bio-Rad Laboratories, Inc. $BIO

Cetera Investment Advisers Boosts Holdings in Bio-Rad Laboratories, Inc. $BIO

Cetera Investment Advisers increased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 12.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,932 shares of the medical research company’s stock after buying an additional 215 shares during the quarter. Cetera Investment Advisers’ holdings in Bio-Rad Laboratories were worth $471,000 at…

Charles Schwab Investment Management Inc. Purchases 11,313 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)

Charles Schwab Investment Management Inc. increased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 5.9% during the 1st quarter, Holdings Channel reports. The firm owned 203,180 shares of the medical research company’s stock after acquiring an additional 11,313 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Bio-Rad Laboratories were […]